bay2353

Niclosamide is a classic salicylanilide antiparasitic drug and a multi-target, low-toxicity, broad-spectrum small-molecule modulator with anthelmintic and antitumor activity. Niclosamide disrupts the parasite’s energy metabolism by uncoupling mitochondrial oxidative phosphorylation, leading to reduced ATP production and ultimately killing the parasite. Niclosamide is a STAT3 inhibitor with an IC50 of 0.25 μM in HeLa cells.

Niclosamide olamine (Niclosamide Ethanolamine salt) is an Repellent, Insect Attractant and Chemosterilant.

Niclosamide sodium (BAY2353), an orally active antihelminthic agent employed in parasitic infection research, serves as a potent STAT3 inhibitor, demonstrating an IC50 of 0.25 μM in HeLa cells. Additionally, this compound exhibits significant biological activities against cancer and effectively inhibits DNA replication in Vero E6 cells.

Niclosamide-13C6 is the 13C6-labeled form of Niclosamide. Niclosamide (T0711) (BAY2353) is an orally bioavailable chlorinated salicylanilide with anthelmintic and potential antineoplastic properties. It inhibits STAT3 with an IC50 of 0.25 μM in HeLa cells and suppresses DNA replication in cell-free assays.

Niclosamide (Standard) is the standard substance of Niclosamide, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. Niclosamide (Niclocide)(BAY2353) is used to treat most tapeworm infections by inhibiting DNA replication.